Javascript must be enabled to continue!
Different p53 Genotypes Regulate PPARγ Post-Translational Modification in The Adipogenic Differentiation of Cancer Cells
View through CrossRef
Abstract
Background: Our previous studies confirmed that high concentrations of cobalt chloride (CoCl2) can induce the formation of polyploid giant cancer cells (PGCCs). PGCCs have the properties of cancer stem cell. In this study, we demonstrate that PGCCs can be induced to differentiate into adipose in vitro and in vivo. In addition, the molecular mechanism of adipogenic differentiation of PGCCs with daughter cells was investigated by detecting the expression of adipocyte differentiation related proteins in mutant and wild-type p53 cancer cell lines. Methods: HEY and MDA-MB-231 control cells and PGCCs with daughter cells were cultured with adipogenic differentiation medium and the cell cycle was detected by flow cytometry. The expression of adipocyte differentiation related proteins, and P300 histone acetyltransferase activity were compared before and after adipogenic differentiation. Immunoprecipitation was used to analyze the post-translational modification of peroxisome proliferator-activator receptor-γ (PPARγ) and P53 in HEY and MDA-MB-231 control cells and PGCCs with daughter cells cultured with adipogenic differentiation medium. Animal xenograft models were used to study the adipogenic differentiation of PGCCs with daughter cells.Results: Dexamethasone, rosiglitazone, insulin, and 3-isobutyl-1-methylxanthine (IBMX) can force the trans-differentiation of PGCCs into post-mitotic and functional adipocytes. Activation of PPARγ is a critical step in the process of adipogenic differentiation. The expression levels of p-CREBser133, PPARγ, C/EBPα, C/EBPβ were higher in PGCCs with daughter cells after adipogenic differentiation compared with those without adipogenic differentiation in HEY and MDA-MB-231. P53 regulates the acetylation and phosphorylation of PPARγ and the expression of P300- Acetyl-PPARγ(Lys)- FABP4 and ERK- Phospho-PPARγ (Ser112)-FABP4 depended upon the genotype of p53 in HEY and MDA-MB-231 cells after cultured with adipogenic differentiation medium. The invasion and migration abilities of PGCCs with their daughter cells after adipogenic differentiation decreased compared with those cells without adipogenic differentiation.Conclusion: P300-P53-ERK-CREB-PPARγ-CEBPα/β-FABP4 pathway may participate in the adipogenic differentiation of HEY, MDA-MB-231 PGCCs with daughter cells, which associated with genotype of p53.
Springer Science and Business Media LLC
Title: Different p53 Genotypes Regulate PPARγ Post-Translational Modification in The Adipogenic Differentiation of Cancer Cells
Description:
Abstract
Background: Our previous studies confirmed that high concentrations of cobalt chloride (CoCl2) can induce the formation of polyploid giant cancer cells (PGCCs).
PGCCs have the properties of cancer stem cell.
In this study, we demonstrate that PGCCs can be induced to differentiate into adipose in vitro and in vivo.
In addition, the molecular mechanism of adipogenic differentiation of PGCCs with daughter cells was investigated by detecting the expression of adipocyte differentiation related proteins in mutant and wild-type p53 cancer cell lines.
Methods: HEY and MDA-MB-231 control cells and PGCCs with daughter cells were cultured with adipogenic differentiation medium and the cell cycle was detected by flow cytometry.
The expression of adipocyte differentiation related proteins, and P300 histone acetyltransferase activity were compared before and after adipogenic differentiation.
Immunoprecipitation was used to analyze the post-translational modification of peroxisome proliferator-activator receptor-γ (PPARγ) and P53 in HEY and MDA-MB-231 control cells and PGCCs with daughter cells cultured with adipogenic differentiation medium.
Animal xenograft models were used to study the adipogenic differentiation of PGCCs with daughter cells.
Results: Dexamethasone, rosiglitazone, insulin, and 3-isobutyl-1-methylxanthine (IBMX) can force the trans-differentiation of PGCCs into post-mitotic and functional adipocytes.
Activation of PPARγ is a critical step in the process of adipogenic differentiation.
The expression levels of p-CREBser133, PPARγ, C/EBPα, C/EBPβ were higher in PGCCs with daughter cells after adipogenic differentiation compared with those without adipogenic differentiation in HEY and MDA-MB-231.
P53 regulates the acetylation and phosphorylation of PPARγ and the expression of P300- Acetyl-PPARγ(Lys)- FABP4 and ERK- Phospho-PPARγ (Ser112)-FABP4 depended upon the genotype of p53 in HEY and MDA-MB-231 cells after cultured with adipogenic differentiation medium.
The invasion and migration abilities of PGCCs with their daughter cells after adipogenic differentiation decreased compared with those cells without adipogenic differentiation.
Conclusion: P300-P53-ERK-CREB-PPARγ-CEBPα/β-FABP4 pathway may participate in the adipogenic differentiation of HEY, MDA-MB-231 PGCCs with daughter cells, which associated with genotype of p53.
Related Results
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract
The tumor suppressor p53 is mutated in more than 50% of all cancers. The transcriptional activity of p53 depends on localization to the nucleus and formatio...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancer
Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancer
The importance of PPARγ (peroxisome proliferator‐activated receptor γ) in gastric cancer (GC) is unclear. We investigated the role of PPARγ in GC cell lines and an animal model, an...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Histone Acetylation Retards the Adipogenic Differentiation of Human Umbilical
Cord - Mesenchymal Stem Cells: A Clue for Anti-obesity Approach?
Histone Acetylation Retards the Adipogenic Differentiation of Human Umbilical
Cord - Mesenchymal Stem Cells: A Clue for Anti-obesity Approach?
aims:
To investigate the epigenetic changes associated with adipogenic differentiation in human umbilical cord blood-derived mesenchymal stem cells (hUCMSCs) us...
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract
Although the main function of p53 is a nuclear transcription factor that has important roles in cell cycle arrest, DNA repair, and apoptosis, p53 can direct...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 829: p53 dimers elicit tumor suppressive activities through an altered metabolic program
Abstract 829: p53 dimers elicit tumor suppressive activities through an altered metabolic program
Abstract
p53 is the most frequently mutated gene in human cancer. As a tetrameric transcription factor, mutation of the p53 Tetramerization Domain (TD) is a mechanis...

